Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesAmmonia as a Potential Neurotoxic Factor in Alzheimer's DiseaseRedox Imbalance and Viral Infections in Neurodegenerative DiseasesA systematic review of type 2 diabetes mellitus and hypertension in imaging studies of cognitive aging: time to establish new normsAlzheimer's disease and type 2 diabetes via chronic inflammatory mechanismsMechanisms underlying inflammation in neurodegenerationOsmoprotective transcription factor NFAT5/TonEBP modulates nuclear factor-kappaB activity.Semantic integration of data on transcriptional regulation.Glia Maturation Factor and Mitochondrial Uncoupling Proteins 2 and 4 Expression in the Temporal Cortex of Alzheimer's Disease BrainAdiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicityBioAge: toward a multi-determined, mechanistic account of cognitive aging.Novel functions for NFκB: inhibition of bone formationMolecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture.The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic ReviewRetinoic acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-κB signaling pathwayEvidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.Studying micro RNA Function and Dysfunction in Alzheimer's DiseaseNF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorderNFκB signaling regulates embryonic and adult neurogenesis.Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.Quercetin Isolated from Toona sinensis Leaves Attenuates Hyperglycemia and Protects Hepatocytes in High-Carbohydrate/High-Fat Diet and Alloxan Induced Experimental Diabetic Mice.Amyloid-β production: major link between oxidative stress and BACE1.Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Transcriptional and post-transcriptional regulation of β-secretase.Inhibition of IKKβ by celastrol and its analogues - an in silico and in vitro approach.Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.Raf kinase inhibitor protein regulates oxygen-glucose deprivation-induced PC12 cells apoptosis through the NF-κB and ERK pathways.Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia.15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferAntimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-κB and NLRP3 inflammasome activation.Morphological adaptation of muscle collagen and receptor of advanced glycation end product (RAGE) in osteoarthritis patients with 12 weeks of resistance training: influence of anti-inflammatory or glucosamine treatment.Memory enhancement and protective effects of crocin against D-galactose aging model in the hippocampus of Wistar rats.Lycopene inhibits regulator of calcineurin 1-mediated apoptosis by reducing oxidative stress and down-regulating Nucling in neuronal cells.Potential dual role of nuclear factor-kappa B in experimental subarachnoid hemorrhage-induced early brain injury in rabbits.Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.
P2860
Q24289511-631C1ECB-33AD-4D9E-9588-E26193E7D1FFQ26739873-F2AE0561-E165-4366-A55F-CBE754B75552Q26750630-914E3D31-F70C-45CE-98E4-782393E2B5C0Q26827439-B25F3E84-597A-483D-9573-74663F4998DCQ28086892-309585D9-B75A-4B55-A249-D77BBB006F39Q29617977-AF1470A4-082E-463B-87D3-FAA905122D3BQ30496797-7AD8CE0A-D7D0-46FC-B4D4-7C5A4FFE61D1Q33567546-4CE28569-4287-4849-A2E3-AB34DC347158Q33700737-9B28C363-5581-4DB4-9F09-C77BD66F8578Q34540588-D29751DD-B352-4292-B166-B4BA61B0D9F9Q34644175-AD222A50-C236-4192-B79E-EEC30AB01CB9Q34806538-00A5B351-DD9F-4F7B-BCBD-CBA15E37DB49Q35667311-A9F3EB1B-A536-4C27-BAFB-51E19A433305Q36140820-4E328EC2-B6C2-41FA-95B3-E2BDDCEB49F2Q36223734-EE139CE6-C18A-4237-AC15-4075A617B9F6Q36315787-6CC181E4-D4D3-45E2-9586-4BD8A6164197Q36488014-21083510-5393-4E6B-B63F-948D0BA4CE8CQ36589571-31C42AAE-A898-4A6B-8450-84543FDA55CEQ36632979-CC18AD5B-88AF-4A6C-A22D-9F6D17DBB468Q36710294-F4313B29-CC17-47EA-A935-96B96B98634FQ37111824-AF2B18B2-B81E-4CBA-83F1-169670B45EDCQ37373888-C062BA18-9807-43DD-AF86-92E085771941Q37406597-C87FB61E-08F0-48EC-B0CC-47DC48268D26Q37448581-D12501FD-E153-45AB-A2DF-286A001A4594Q37946306-747856E3-2559-43E1-ACFF-3B9CFC4691E3Q37982377-74783766-C77F-46DB-8C34-7D8C4913E43CQ38062499-71932551-68BF-484F-ACA4-0F402A06C6F2Q38727093-65868434-4822-4256-9815-89A00C7BCC43Q38798483-D6349C98-DF30-4003-91DF-573A0A896D1FQ39906670-0726B9F9-F43F-4DFA-A1A1-90B3CC2F0C40Q40683231-60132924-2B1A-4857-A7C1-5B84DE6CEAF9Q41062215-DF89C682-8BE1-47A5-93BC-30A00A01F507Q41203727-F2567EF1-D513-47A4-B9DE-60E312510F6DQ45254835-A2CB3780-C7C9-48F3-89B2-3AC93A10EFB5Q45342642-ABDC7C95-EA37-4DAF-A2B0-A714BD3E1C43Q45817707-93971276-9676-4D73-8CFB-3A4DC8470CA8Q47101533-600A7464-C354-4DA2-B3EE-547785B62A36Q48024711-CC664BF4-A5D3-4F47-ACFB-43A73BCC94EEQ48467024-2CF33ACD-528B-4A66-A024-508BD14A8811Q48553675-8D9747CD-5B27-4141-89B2-9AEBDB014D65
P2860
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
@en
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
@nl
type
label
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
@en
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
@nl
prefLabel
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
@en
Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
@nl
P50
P356
P1476
Inflammation and NF-kappaB in Alzheimer's disease and diabetes
@en
P2093
Ingrid M Nijholt
Ivica Granic
P304
P356
10.3233/JAD-2009-0976
P577
2009-01-01T00:00:00Z